Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells)-;cells in the pancreas that produce and distribute insulin.

4 Aug 2022

Study: Children with type 1 diabetes and their family members are at increased risk of mental health problems

Both children with type 1 diabetes and their closest family members are at increased risk of mental health problems compared with those without the disease, according to a large study by researchers at Karolinska Institutet in Sweden published in the journal Diabetes Care.

1 Aug 2022

Higher insulin dose is positively linked with cancer incidence, study finds

Dr. Yuanjie Mao has led a study published in the Journal of the American Medical Association (JAMA) Oncology looking at the correlation between daily insulin dose and cancer incidence (the number of new cases) among patients with type 1 diabetes, finding that higher insulin dose is positively associated with cancer incidence and that the association is stronger among those with insulin resistance.

29 Jul 2022

Icelandic study reveals how many children experience severe COVID symptoms

Researchers explore the incidence of SARS-CoV-2 infections in Icelandic children.

27 Jul 2022

A major breakthrough toward new treatments for Type 1 and Type 2 diabetes

A world-first study by Monash University, in Melbourne, Australia has discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes.

22 Jul 2022

Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics

People with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin, have no choice but to inject themselves regularly with artificial insulin in order to survive.

18 Jul 2022

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

14 Jul 2022

Researchers may be one step closer to preventing Type 1 diabetes

Australian researchers may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold.

14 Jul 2022

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

In a new study, researchers reported that Pfizer’s BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 does not affect the honeymoon phase of type 1 diabetes (T1D).

13 Jul 2022

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system's history with other coronaviruses, including those behind the common cold, shapes the patient's response, according to a study published today in Cell Reports.

6 Jul 2022

COVID vaccines protect people of all body weights

In a recent study published in The Lancet, researchers in the United Kingdom determined whether an individual with a higher body mass index (BMI) mounted a weaker immune response to a coronavirus disease 2019 (COVID-19) vaccine.

4 Jul 2022

Brigham receives $16 million Helmsley Charitable Trust grant to improve healthcare delivery for NCDs

Brigham and Women's Hospital announces a $16 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to support the implementation and evaluation of an integrated service delivery model (PEN-Plus) for severe chronic noncommunicable diseases (NCDs) such as type 1 diabetes, rheumatic heart disease, cardiomyopathies, and sickle cell disease in eight low- and lower-middle-income countries in sub-Saharan Africa and South Asia.

1 Jul 2022

New study looks at the role of beta cells in triggering autoimmunity

Research into the causes of type 1 diabetes often focuses on the autoimmune response, where the immune system destroys pancreatic islet beta cells that produce insulin.

28 Jun 2022

Study finds unequal access to life-changing device among youth with type 1 diabetes

Over the past 20 years, despite the overall increase in the use of insulin pumps, there have been few improvements in the ethnic, racial and socioeconomic inequities in insulin pump use among youth with type 1 diabetes, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

14 Jun 2022

Study demonstrates a potential way to stimulate the formation of new insulin-producing cells

Researchers at Karolinska Institutet in Sweden show how a molecule that they have identified stimulates the formation of new insulin-producing cells in zebrafish and mammalian tissue, through a newly described mechanism for regulating protein synthesis.

13 Jun 2022

Researchers demonstrate the feasibility of pancreatic beta-cell, target-specific CAR-Treg treatment for T1D

Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to treat the human condition according to data being presented Monday, June 13 at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

13 Jun 2022

Stem cell-based therapy shows potential to provide blood sugar control in patients with high-risk type 1 diabetes

An investigative stem cell-based therapy called PEC-Direct, designed to act as a replacement pancreas, has the potential to provide blood sugar control in patients with high-risk type 1 diabetes, suggests a clinical study presented Saturday, June 11 at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

13 Jun 2022

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

Study: Children with type 1 diabetes and their family members are at increased risk of mental health problems

Higher insulin dose is positively linked with cancer incidence, study finds

Icelandic study reveals how many children experience severe COVID symptoms

A major breakthrough toward new treatments for Type 1 and Type 2 diabetes

Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Researchers may be one step closer to preventing Type 1 diabetes

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

COVID vaccines protect people of all body weights

Brigham receives $16 million Helmsley Charitable Trust grant to improve healthcare delivery for NCDs

New study looks at the role of beta cells in triggering autoimmunity

Study finds unequal access to life-changing device among youth with type 1 diabetes

Study demonstrates a potential way to stimulate the formation of new insulin-producing cells

Researchers demonstrate the feasibility of pancreatic beta-cell, target-specific CAR-Treg treatment for T1D

Stem cell-based therapy shows potential to provide blood sugar control in patients with high-risk type 1 diabetes

Older adults with Type 1 diabetes have greater risk for muscle weakening, cardiovascular complications

Study offers insights into genetic factors that affect immunological responses in type 1 diabetes

ASU study explores components of the immune system

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in